(Q43923055)

28 November 2017

title

Successful treatment of restless legs syndrome with an implanted pump for intrathecal drug delivery (English)

1 reference

28 November 2017

1 reference

restless legs syndrome

1 reference

Jakobsson B

1

1 reference

28 November 2017

Ruuth K

series ordinal

2

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

Acta Anaesthesiologica Scandinavica

28 November 2017

published in

1 reference

28 November 2017

volume

46

1 reference

28 November 2017

issue

1

1 reference

28 November 2017

page(s)

114-117

1 reference

Circadian rhythm of motor restlessness and sensory symptoms in the idiopathic restless legs syndrome.

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2002.460121.X

Peridural morphine administration in restless legs status

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2002.460121.X

Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2002.460121.X

Clinical realities and economic considerations: efficacy of intrathecal pain therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2002.460121.X

Restless legs syndrome and its treatment by dopamine agonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2002.460121.X

Subclinical sensory neuropathy in late-onset restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2002.460121.X

Insight into the pathophysiology of restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2002.460121.X

MRI measurement of brain iron in patients with restless legs syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2002.460121.X

Opioid and dopamine antagonist drug challenges in untreated restless legs syndrome patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2002.460121.X

Restless legs and periodic leg movements in sleep syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2002.460121.X

7 January 2021

Augmentation of the restless legs syndrome with carbidopa/levodopa.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2002.460121.X

7 January 2021

Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2002.460121.X

7 January 2021

Long-term intrathecal morphine and bupivacaine in patients with refractory cancer pain. Results from a morphine:bupivacaine dose regimen of 0.5:4.75 mg/ml.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2002.460121.X

7 January 2021

Pergolide and carbidopa/levodopa treatment of the restless legs syndrome and periodic leg movements in sleep in a consecutive series of patients.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2002.460121.X

7 January 2021

10.1034/J.1399-6576.2002.460121.X

Identifiers

DOI

1 reference

28 November 2017

1 reference